UNSPSC 51284607: Doripenem hydrate

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B035T6NKT. European Medicines Agency schedules Doripenem hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26847. Doripenem hydrate generally arises in the molecular formula C15H24N4O6S2.H2O. The term 'doripenem hydrate' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule doripenem hydrate under HS 29419000.

SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O.O.

UNSPSC 51284607 Doripenem hydrate is a Commodity code nominally identifying a specific antibiotic pharmaceutical, but recent state and local solicitations tagged with this code show little activity directly aligned with doripenem procurement; the code appears underutilized or misapplied in current state and local contracting practice. The source reveals four recent opportunities where this code was applied, yet only one—the Seminole County, Florida naloxone procurement—names a specific pharmaceutical product that resembles the code's nominal scope, and that product (naloxone, an opioid antagonist) differs substantially from doripenem (a broad-spectrum antibiotic). The Texas Health and Human Services Commission RFI on direct-to-manufacturer prescriptions and the Minnesota Multistate Cooperative Purchasing Alliance generic pharmaceutical RFP address pharmaceutical supply chain frameworks rather than a single drug entity, while the City of Tampa's medical and first aid supplies solicitation covers a broad array of emergency response consumables with no doripenem specification. Issuing bodies in the recent record include a county health department (Seminole County), a state health agency (Texas HHS), a cooperative purchasing alliance spanning multiple states (MMCAP), and a municipal fire department (City of Tampa), reflecting the diversity of public-sector pharmaceutical procurement. Geographic activity is scattered across Florida, Texas, Minnesota, and Oregon, with no clear concentration in any single jurisdiction or region.

The most concrete recent opportunity under this code is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (note: the posted and due dates are inconsistent in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. The Minnesota MMCAP RFP (S1070000015802) closing March 26, 2026, establishes a multi-state contracting vehicle for generic pharmaceuticals and OTC products through three authorized wholesalers, with awards effective July 1, 2026, though no specific doripenem demand is identified. The Texas HHS RFI (HHS0017013) posted April 3, 2026, is an exploratory information-gathering mechanism to understand vendor capacity for direct-to-manufacturer prescription programs rather than a formal procurement with binding timelines. Bid activity under this code does not currently demonstrate sustained demand for doripenem specifically; procurement professionals should verify whether their dorimenem products align with broader generic pharmaceutical contracting vehicles or state health agency supply agreements before pursuing opportunities.